Citigroup’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.8M Buy
851,001
+326,996
+62% +$7.7M 0.01% 1126
2026
Q1
$7.84M Sell
524,005
-1,832,658
-78% -$31.3M ﹤0.01% 1620
2025
Q4
$34.3M Buy
2,356,663
+944,846
+67% +$16.5M 0.02% 803
2025
Q3
$25.3M Sell
1,411,817
-404,753
-22% -$5.94M 0.01% 935
2025
Q2
$31M Buy
1,816,570
+1,243,293
+217% +$12.4M 0.02% 762
2025
Q1
$4.15M Sell
573,277
-27,667
-5% -$315K ﹤0.01% 2067
2024
Q4
$8.44M Buy
600,944
+439,734
+273% +$6.5M 0.01% 1505
2024
Q3
$1.91M Buy
161,210
+67,486
+72% +$699K ﹤0.01% 2703
2024
Q2
$872K Buy
93,724
+81,769
+684% +$418K ﹤0.01% 3006
2024
Q1
$42.3K Buy
+11,955
New +$41.5K ﹤0.01% 4701

Other funds holding CORZ

Citigroup's CORZ Position: Q2 2026 in Review

Citigroup increased its Core Scientific (CORZ) stake by 62% in Q2 2026, buying an estimated $7.7M and bringing the position to 851,001 shares worth $21.8M. The position accounts for 0.01% of the portfolio, ranked #1126.

Citigroup first reported a position in CORZ in Q1 2024 and has held it in 10 quarters since. The position peaked at $34.3M in Q4 2025. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Citigroup held 851,001 shares of Core Scientific worth $21.8M as of Q2 2026.
  • Citigroup bought 326,996 Core Scientific shares in Q2 2026, an estimated $7.7M.
  • Core Scientific made up 0.01% of Citigroup's portfolio in Q2 2026, its #1126 holding.
  • Citigroup first reported a position in Core Scientific in Q1 2024 and has held it in 10 quarters since.
  • Citigroup's Core Scientific position peaked at $34.3M in Q4 2025.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.